Identification of a tumour associated antigen in lung cancer patients with asbestos exposure

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 2631-2639

  Yasuda, Manabu ^a   Hanagiri, Takeshi ^a   Shigematsu, Yoshiki ^a   Onitsuka, Takamitsu ^a   Kuroda, Kouji ^a   Baba, Tetsurou ^a   Mizukami, Makiko ^a   Ichiki, Yoshinobu ^a   Uramoto, Hidetaka ^a   Takenoyama, Mitsuhiro ^a   Yasumoto, Kosei ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Annexin a2, serex; Asbestos; Lung cancer; Tumour antigen

Indexed keywords

ASBESTOS; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; INTERLEUKIN 6; LIPOCORTIN 2; PROTEIN ANTIBODY; PROTEIN KINASE; TRANSFORMING ACIDIC COILED COIL PROTEIN 3; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; ASBESTOSIS; CANCER PATIENT; CANCER RISK; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG PARENCHYMA; LUNG SQUAMOUS CELL CARCINOMA; MALE; MALIGNANT MESOTHELIOMA; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; TUMOR SUPPRESSOR GENE;

AGED; AGED, 80 AND OVER; ANNEXIN A2; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; ASBESTOS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; INTERLEUKIN-6; LUNG NEOPLASMS; MALE; MESOTHELIOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77955826758     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Doll R: Mortality from lung cancer in asbestos workers. Br J Ind Med 12: 81-86, 1955.
2. Karjalainen A, Anttila S, Heikkila L, Kyyronen P and Vainio H: Lobe of origin of lung cancer among asbestos-exposed patients with or without diffuse interstitial fibrosis. Scand J Work Environ Health 19: 102-107, 1993. (Pubitemid 23146425)
3. Sluis-Cremer GK and Bezuidenhout BN: Relation between asbestosis and bronchial cancer in amphibole asbestos miners. Br J Ind Med 46: 537-540, 1989.
4. Hughes JM and Weill H: Asbestosis as a precursor of asbestos related lung cancer: Results of a prospective mortality study. Br J Ind Med 48: 229-233, 1991.
5. Reid A, De Klerk N, Ambrosini GL, Olsen N, Pang SC, Berry G and Musk AW: The effect of asbestosis on lung cancer risk beyond the dose-related effect of asbestos alone. Occup Environ Med 62: 885-889, 2005. (Pubitemid 41729779)
6. Consensus report. Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health 23: 311-316, 1997.
7. Karjalainen A, Anttila S, Vanhala E and Vainio H: Asbestos exposure and the risk of lung cancer in a general urban population. Scand J Work Environ Health 20: 243-250, 1994. (Pubitemid 24291306)
8. De Vos Irvine H, Lamont DW, Hole DJ and Gillis CR: Asbestos and lung cancer in Glasgow and the west of Scodland BMJ 306: 1503-1506, 1993.
9. Kjuus H, Langard S and Skjaerven R: A case-referent study of lung cancer, occupational exposure and smoking: III. Etiologic fraction of occupational exposures. Scand J Work Environ Health 12: 210-215, 1986. (Pubitemid 16073789)
10. Sahin U, Türeci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I and Pfreundschuh M: Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92: 11810-11813, 1995. (Pubitemid 26014201)
11. Brass N, Heckel D, Sahin U, Pfreundschuh M, Sybrecht GW and Meese E: Translation initiation factor eIF-4 gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Hum Mol Genet 6: 33-39, 1997. (Pubitemid 27033962)
12. Brass N, Racz A, Bauer C, Heckel D, Sybrecht G and Meese E: Role of amplified genes in the production of autoantibodies. Blood 93: 2158-2166, 1999. (Pubitemid 29153615)
13. Güre AO, Altorki NK, Stockert E, Scanlan MJ, Old LJ and Chen YT: Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3. Cancer Res 58: 1034-1041, 1998. (Pubitemid 28182475)
14. Güre AO, Stockert E, Scanlan MJ, Keresztes RS, Jager D, Altorki NK, Old LJ and Chen YT: Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc Natl Acad Sci USA 97: 4198-4203, 2000. (Pubitemid 30226110)
15. Yasuda M, Takenoyama M, Obata Y, Sugaya M, So T, Hanagiri T, Sugio K and Yasumoto K: Tumor-infiltrating B lymphocytes as a potential source of identifying tumor antigen in human lung cancer. Cancer Res 62: 1751-1756, 2002. (Pubitemid 34408498)
16. Mizukami M, Hanagiri T, Baba T, Fukuyama T, Nagata Y, So T, Ichiki Y, Sugaya M, Yasuda M, Takenoyama M, Sugio K and Yasumoto K: Identification of tumor associated antigens recognized by IgG from tumor-infiltrating B-cells of lung cancer: correlation between Ab titer of the patient's sera and the clinical course. Cancer Sci 96: 882-888, 2005. (Pubitemid 43056127)
17. Yasuda M, Mizukami M, Hanagiri T, Shigematsu Y, Fukuyama T, Nagata Y, So T, Ichiki Y, Sugaya M, Takenoyama M, Sugio K and Yasumoto K: Antigens recognized by IgG derived from tumor-infiltrating B lymphocytes in human lung cancer. Anticancer Res 26: 3607-3611, 2006. (Pubitemid 44701546)
18. Mizukami M, Hanagiri T, Yasuda M, Kuroda K, Shigematsu Y, Baba T, Fukuyama T, Nagata Y, So T, Ichiki Y, Sugaya M, So T, Takenoyama M, Sugio K and Yasumoto K: Antitumor effect of antibody against a SEREX-defined antigen (UOEH-LC-1) on lung cancer xenotransplanted into severe combined immunodeficiency mice. Cancer Res 67: 8351-8357, 2007. (Pubitemid 47395174)
19. Victor LR and Linda LS: Asbestos Content of Lung Tissue and Carcinoma of the Lung: a clinicopathologic correlation and mineral fiber analysis of 234 cases. Ann Occup Hyg 44: 109-117, 2000.
20. Mollo F, Magnani C, Bo P, Burlo P and Cravello M: The attribution of lung cancers to asbestos exposure a pathologic study of 924 unselected cases. Am J Clin Pathol 117: 90-95, 2002. (Pubitemid 34052477)
21. Yasuda M, Tanaka Y, Tamura M, Fujii K, Sugaya M, So T, Takenoyama M and Yasumoto K: Stimulation of beta1 integrin down-regulates ICAM-1 expression and ICAM-1-dependent adhesion of lung cancer cells through focal adhesion kinase. Cancer Res 61: 2022-2030, 2001. (Pubitemid 32692023)
22. Shigematsu Y, Hanagiri T, Kuroda K, Baba T, Mizukami M, Ichiki Y, Yasuda M, Takenoyama M, Sugio K and Yasumoto K: Malignant mesothelioma-associated antigens recognized by tumor-infiltrating B-cells and the clinical significance of the antibody titers. Cancer Sci 100: 1326-1334, 2009.
23. Shao C, Zhang F, Kemp MM, Linhardt RJ, Waisman DM, Head JF and Seaton BA: Crystallographic analysis of calcium-dependent heparin binding to annexin A2. J Biol Chem 281: 31689-31695, 2006. (Pubitemid 46041433)
24. Peset I and Vernos I: The TACC proteins: TACC-ling microtubule dynamics and centrosome function. Trends Cell Biol 18: 379-388, 2008.
25. Zhang XM, Sheng SR, Wang XY, Bin LH, Wang JR and Li GY: Expression of tumor related gene NAG6 in gastric cancer and restriction fragment length polymorphism analysis. World J Gastroenterol 10: 1361-1364, 2004.
26. Zhou Y, Toth M, Hamman MS, Monahan SJ, Lodge PA, Boynton AL and Salgaller ML: Serological cloning of PARIS-1: a new TBC domain-containing, immunogenic tumor antigen from a prostate cancer cell line. Biochem Biophys Res Commun 290: 830-838, 2002. (Pubitemid 34687518)
27. Khan IU, Laxminarayana D and Kammer GM: Protein kinase A RI beta subunit deficiency in lupus T lymphocytes: bypassing a block in RI beta translation reconstitutes protein kinase A activity and augments IL-2 production. J Immunol 166: 7600-7605, 2001. (Pubitemid 32525641)
28. Brichory FM, Misek DE, Yim AM, Krause MC, Giordano TJ, Beer DG and Hanash SM: An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci USA 98: 9824-9829, 2001.
29. Ilavská S, Jahnová E, Tulinská J, Horváthová M, Dusinská M, Wsolová L, Kyrtopoulos SA and Fuortes L: Immunological monitoring in workers occupationally exposed to asbestos. Toxicology 206: 299-308, 2005. (Pubitemid 39601040)
30. Mohammad HS, Kurokohchi K, Yoneyama H, Tokuda M, Morishita A, Jian G, Shi L, Murota M, Tani J, Kato K, Miyoshi H, Deguchi A, Himoto T, Usuki H, Wakabayashi H, Izuishi K, Suzuki Y, Iwama H, Deguchi K, Uchida N, Sabet EA, Arafa UA, Hassan AT, El-Sayed AA and Masaki T: Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Int J Oncol 33: 1157-1163, 2008.
31. Pena-Alonso E, Rodrigo JP, Parra IC, Pedrero JM, Meana MV, Nieto CS, Fresno MF, Morgan RO and Fernandez MP: Annexin A2 localizes to the basal epithelial layer and is down-regulated in dysplasia and head and neck squamous cell carcinoma. Cancer Lett 263: 89-98, 2008.
32. Sharma MC and Sharma M: The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target. Curr Pharm Des 13: 3568-3575, 2007. (Pubitemid 350238927)
33. Ortiz-Zapater E, Peiró S, Roda O, Corominas JM, Aguilar S, Ampurdanés C, Real FX and Navarro P: Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2. Am J Pathol 170: 1573-1584, 2007. (Pubitemid 47339302)
34. Hurbánková M and Kaiglová A: The changes of some immunological parameters in subjects exposed to asbestos in dependence on age, duration of exposure, radiological findings and smoking habits. Zentralbl Hyg Umweltmed 195: 55-65, 1993.
35. Nishimura Y, Nishiike-Wada T, Wada Y, Miura Y, Otsuki T and Iguchi H: Long-lasting production of TGF-beta1 by alveolar macrophages exposed to low doses of asbestos without apoptosis. Int J Immunopathol Pharmacol 20: 661-671, 2007.
36. Inokuchi J, Narula N, Yee DS, Skarecky DW, Lau A, Ornstein DK and Tyson DR: Annexin A2 positively contributes to the malignant phenotype and secretion of IL-6 in DU145 prostate cancer cells. Int J Cancer 124: 68-74, 2009.
37. Fukuyama T, Ichiki Y, Yamada S, Shigematsu Y, Baba T, Nagata Y, Mizukami M, Sugaya M, Takenoyama M, Hanagiri T, Sugio K and Yasumoto K: Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/immunological responses both in vivo and in vitro. Cancer Sci 98: 1048-1054, 2007. (Pubitemid 46865390)
38. Studebaker AW, Storci G, Werbeck JL, Sansone P, Sasser AK, Tavolari S, Huang T, Chan MW, Marini FC, Rosol TJ, Bonafé M and Hall BM: Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res 68: 9087-9095, 2008.